2176 - In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Cystic Fibrosis Patients Hospitalized with Pneumonia: Results from the SENTRY Antimicrobial Surveillance Program (2019-2021)

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Dee Shortridge, PhD

Senior Director Microbiology
JMI Laboratories
North Liberty, Iowa, United States

JS

Jennifer M. Streit, BS, MT(ASCP)

Surveillance Manager
JMI Laboratories
North Liberty, Iowa, United States
MH

Michael D. Huband, BS

Associate Director for Clinical Microbiology
JMI Laboratories
North Liberty, Iowa, United States
Mariana Castanheira, PhD

Chief Scientific Officer
JMI Laboratories
North Liberty, Iowa, United States